{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:56:40Z","timestamp":1790665000694,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540254270","type":"print"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/3-540-37673-9_10","type":"book-chapter","created":{"date-parts":[[2006,10,29]],"date-time":"2006-10-29T21:36:43Z","timestamp":1162157803000},"page":"161-186","source":"Crossref","is-referenced-by-count":59,"title":["TNF Blockade: An Inflammatory Issue"],"prefix":"10.1007","author":[{"given":"B. B.","family":"Aggarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Shishodia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Jackson-Bernitsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. S.","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nri1184","volume":"3","author":"B.B. Aggarwal","year":"2003","unstructured":"Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3:745\u2013756","journal-title":"Nat Rev Immunol"},{"key":"10_CR2","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0021-9258(17)43716-1","volume":"259","author":"B.B. Aggarwal","year":"1984","unstructured":"Aggarwal BB, Moffat B, Harkins RN (1984) Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization. Biol J Chem 259:686\u2013691","journal-title":"Biol J Chem"},{"key":"10_CR3","first-page":"5156","volume":"56","author":"B.B. Aggarwal","year":"1996","unstructured":"Aggarwal BB, Schwarz L, Hogan ME, Rando RF (1996) Triple helix-forming oligodeoxyribonucleotides targeted to the human tumor necrosis factor (TNF) gene inhibit TNF production and block the TNF-dependent growth of human glioblastoma tumor cells. Cancer Res 56:5156\u20135164","journal-title":"Cancer Res"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2174\/1568010023344571","volume":"1","author":"B.B. Aggarwal","year":"2002","unstructured":"Aggarwal BB, Shishodia S, Ashikawa K, Bharti AC (2002) The role of TNF and its family members in inflammation and cancer: lessons from gene deletion. Curr Drug Targets Inflamm Allergy 1:327\u2013341","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10_CR5","first-page":"2783","volume":"24","author":"B.B. Aggarwal","year":"2004","unstructured":"Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24:2783\u20132840","journal-title":"Anticancer Res"},{"key":"10_CR6","doi-asserted-by":"publisher","first-page":"27098","DOI":"10.1074\/jbc.M104486200","volume":"276","author":"P. Ameloot","year":"2001","unstructured":"Ameloot P, Declercq W, Fiers W, Vandenabeele P, Brouckaert P (2001) Heterotrimers formed by tumor necrosis factors of different species or muteins. Biol J Chem 276:27098\u201327103","journal-title":"Biol J Chem"},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/sj.onc.1207317","volume":"23","author":"C.H. Arnott","year":"2004","unstructured":"Arnott CH, Scott KA, Moore RJ, Robinson SC, Thompson RG, Balkwill FR (2004) Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development. Oncogene 23:1902\u20131910","journal-title":"Oncogene"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2165\/00063030-200418050-00003","volume":"18","author":"X. Baraliakos","year":"2004","unstructured":"Baraliakos X, Braun J (2004) Current concepts in the therapy of the spondyloarthritides. BioDrugs 18:307\u2013314","journal-title":"BioDrugs"},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"13681","DOI":"10.1073\/pnas.251194298","volume":"98","author":"B.L. Bennett","year":"2001","unstructured":"Bennett BL, Sasaki DT, Murray BW, O\u2019Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 98:13681\u201313686","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/0923-1811(92)90040-I","volume":"3","author":"B. Berman","year":"1992","unstructured":"Berman B, Wietzerbin J (1992) Tumor necrosis factor-alpha (TNF-alpha), interferon-alpha (IFN-alpha) and interferon-gamma (IFN-gamma) receptors on human normal and scleroderma dermal fibroblasts in vitro. Dermatol J Sci 3:82\u201390","journal-title":"Dermatol J Sci"},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1126\/science.3895437","volume":"229","author":"B. Beutler","year":"1985","unstructured":"Beutler B, Milsark IW, Cerami AC (1985) Passive immunization against cachectin\/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869\u2013871","journal-title":"Science"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1600-0609.1994.tb00176.x","volume":"53","author":"M. Borset","year":"1994","unstructured":"Borset M, Waage A, Brekke OL, Helseth E (1994) TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell line. Eur Haematol J 53:31\u201337","journal-title":"Eur Haematol J"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1074\/jbc.M209677200","volume":"278","author":"J.R. Burke","year":"2003","unstructured":"Burke JR, Pattoli MA, Gregor KR, Brassil PJ, MacMaster JF, McIntyre KW, Yang X, Iotzova VS, Clarke W, Strnad J, Qiu Y, Zusi FC (2003) BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappaB-dependent transcription in mice. J Biol Chem 278:1450\u20131456","journal-title":"J Biol Chem"},{"key":"10_CR14","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.4049\/jimmunol.173.11.6928","volume":"173","author":"J. Campbell","year":"2004","unstructured":"Campbell J, Ciesielski CJ, Hunt AE, Horwood NJ, Beech JT, Hayes LA, Denys A, Feldmann M, Brennan FM, Foxwell BM (2004) A novel mechanism for TNF-alpha regulation by p38 MAPK: involvement of NF-kappaB with implications for therapy in rheumatoid arthritis. Immunol J 173:6928\u20136937","journal-title":"Immunol J"},{"key":"10_CR15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.mrfmmm.2004.02.024","volume":"551","author":"H. Carlsen","year":"2004","unstructured":"Carlsen H, Alexander G, Austenaa LM, Ebihara K, Blomhoff R (2004) Molecular imaging of the transcription factor NF-kappaB, a primary regulator of stress response. Mutat Res 551:199\u2013211","journal-title":"Mutat Res"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0014-4827(89)90053-0","volume":"185","author":"M.S. Chapekar","year":"1989","unstructured":"Chapekar MS, Huggett AC, Thorgeirsson SS (1989) Growth modulatory effects of a liver-derived growth inhibitor, transforming growth factor beta 1, and recombinant tumor necrosis factor alpha, in normal and neoplastic cells. Exp Cell Res 185:247\u2013257","journal-title":"Exp Cell Res"},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1126\/science.1071924","volume":"296","author":"G. Chen","year":"2002","unstructured":"Chen G, Goeddel DV (2002) TNF-R1 signaling: a beautiful pathway. Science 296:1634\u20131635","journal-title":"Science"},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"17070","DOI":"10.1074\/jbc.M312021200","volume":"279","author":"C. Alvaro De","year":"2004","unstructured":"De Alvaro C, Teruel T, Hernandez R, Lorenzo M (2004) Tumor necrosis factor alpha produces insulin resistance inskeletalmuscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependentmanner. Biol J Chem 279:17070\u201317078","journal-title":"Biol J Chem"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1159\/000069965","volume":"206","author":"S.A. Devos","year":"2003","unstructured":"Devos SA, Van Den Bossche N, De Vos M, Naeyaert JM (2003) Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy. Dermatology 206:388\u2013390","journal-title":"Dermatology"},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.canlet.2004.07.013","volume":"215","author":"T. Dorai","year":"2004","unstructured":"Dorai T, Aggarwal BB (2004) Role of chemopreventive agents in cancer therapy. Cancer Lett 215:129\u2013140","journal-title":"Cancer Lett"},{"key":"10_CR21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1084\/jem.177.3.763","volume":"177","author":"Z. Estrov","year":"1993","unstructured":"Estrov Z, Kurzrock R, Pocsik E, Pathak S, Kantarjian HM, Zipf TF, Harris D, Talpaz M, Aggarwal BB (1993) Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines. Exp J Med 177:763\u2013774","journal-title":"Exp J Med"},{"key":"10_CR22","doi-asserted-by":"publisher","first-page":"14008","DOI":"10.1074\/jbc.273.22.14008","volume":"273","author":"D.K. Giri","year":"1998","unstructured":"Giri DK, Aggarwal BB (1998) Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen i ntermediates. Biol J Chem 273:14008\u201314014","journal-title":"Biol J Chem"},{"key":"10_CR23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/01.HYP.33.1.183","volume":"33","author":"S. Goetze","year":"1999","unstructured":"Goetze S, Xi XP, Kawano Y, Kawano H, Fleck E, Hsueh WA, Law RE (1999) TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent. Hypertension 33:183\u2013189","journal-title":"Hypertension"},{"key":"10_CR24","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/0092-8674(95)90192-2","volume":"83","author":"M. Grell","year":"1995","unstructured":"Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K et al. (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793\u2013802","journal-title":"Cell"},{"key":"10_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0304-3835(01)00378-0","volume":"164","author":"S.S. Han","year":"2001","unstructured":"Han SS, Keum YS, Seo HJ, Chun KS, Lee SS, Surh YJ (2001) Capsaicin suppresses phorbol ester-induced activation of NF-kappaB\/Rel and AP-1 transcription factors in mouse epidermis. Cancer Lett 164:119\u2013126","journal-title":"Cancer Lett"},{"issue":"[Suppl 3]","key":"10_CR26","first-page":"S18","volume":"4","author":"S.B. Hanauer","year":"2004","unstructured":"Hanauer SB (2004) Efficacy and safety of tumor necrosis factor antagonists in Crohn\u2019s disease: overviewof randomized clinical studies. Rev Gastroenterol Disord 4[Suppl 3]:S18\u2013S24","journal-title":"Rev Gastroenterol Disord"},{"key":"10_CR27","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.4049\/jimmunol.160.7.3152","volume":"160","author":"V. Haridas","year":"1998","unstructured":"Haridas V, Darnay BG, Natarajan K, Heller R, Aggarwal BB (1998) Over-expression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-kappa B activation, and c-Jun kinase activation. Immunol J 160:3152\u20133162","journal-title":"Immunol J"},{"key":"10_CR28","doi-asserted-by":"publisher","first-page":"16639","DOI":"10.1074\/jbc.M200360200","volume":"277","author":"T. Hideshima","year":"2002","unstructured":"Hideshima T, Chauhan D, Richardson P, Mitsiades C, Mitsiades N, Hayashi T, Munshi N, Dang L, Castro A, Palombella V, Adams J, Anderson KC (2002) NF-kappa B as a therapeutic target in multiple myeloma. J Biol Chem 277:16639\u201316647","journal-title":"J Biol Chem"},{"key":"10_CR29","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1016\/S0960-894X(98)00589-7","volume":"8","author":"J.R. Henry","year":"1998","unstructured":"Henry JR, Rupert KC, Dodd JH, Turchi IJ, Wadsworth SA, Cavender DE, Schafer PH, Siekierka JJ (1998) Potent inhibitors of the MAP kinase p38. Bioorg Med Chem Lett 8:3335\u20133340","journal-title":"Bioorg Med Chem Lett"},{"key":"10_CR30","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00125-004-1503-7","volume":"47","author":"R. Hernandez","year":"2004","unstructured":"Hernandez R, Teruel T, de Alvaro C, Lorenzo M (2004) Rosiglitazone ameliorates insulin resistance in brown adipocytes of Wistar rats by impairing TNF-alpha induction of p38 and p42\/p44 mitogen-activated protein kinases. Diabetologia 47:1615\u20131624","journal-title":"Diabetologia"},{"key":"10_CR31","first-page":"181","volume":"136","author":"S.M. Hsu","year":"1990","unstructured":"Hsu SM, Hsu PL (1990) Lack of effect of colony-stimulating factors, interleukins, interferons, and tumor necrosis factor on the growth and differentiation of cultured Reed-Sternberg cells. Comparison with effects of phorbol ester and retinoic acid. AmPathol J 136:181\u2013189","journal-title":"AmPathol J"},{"key":"10_CR32","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.4049\/jimmunol.172.4.2569","volume":"172","author":"M. Ishii","year":"2004","unstructured":"Ishii M, Suzuki Y, Takeshita K, Miyao N, Kudo H, Hiraoka R, Nishio K, Sato N, Naoki K, Aoki T, Yamaguchi K (2004) Inhibition of c-Jun NH2-terminal kinase activity improves ischemia\/reperfusion injury in rat lungs. Immunol J 172:2569\u20132577","journal-title":"Immunol J"},{"key":"10_CR33","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1126\/science.1072682","volume":"298","author":"G.L. Johnson","year":"2002","unstructured":"Johnson GL, Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911\u20131912","journal-title":"Science"},{"key":"10_CR34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s11926-004-0041-0","volume":"6","author":"D. Kane","year":"2004","unstructured":"Kane D, FitzGerald O (2004) Tumor necrosis factor-alpha in psoriasis a nd psoriatic arthritis: a clinical, genetic, and histopathologic perspective. Curr Rheumatol Rep 6:292\u2013298","journal-title":"Curr Rheumatol Rep"},{"key":"10_CR35","doi-asserted-by":"publisher","first-page":"32861","DOI":"10.1074\/jbc.M211439200","volume":"278","author":"N. Kishore","year":"2003","unstructured":"Kishore N, Sommers C, Mathialagan S, Guzova J, Yao M, Hauser S, Huynh K, Bonar S, Mielke C, Albee L, Weier R, Graneto M, Hanau C, Perry T, Tripp CS (2003) Aselective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts. J Biol Chem 278:32861\u201332871","journal-title":"J Biol Chem"},{"key":"10_CR36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1006\/bbrc.1997.6849","volume":"235","author":"S. Kumar","year":"1997","unstructured":"Kumar S, Mc PCDonnell, Gum RJ, Hand AT, Lee JC, Young PR (1997) Novel homologues of CSBP\/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 235:533\u2013538","journal-title":"Biochem Biophys Res Commun"},{"key":"10_CR37","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S0006-2952(97)00557-1","volume":"55","author":"A. Kumar","year":"1998","unstructured":"Kumar A, Dhawan S, Hardegen NJ, Aggarwal BB (1998a) Curcumin (diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation. Biochem Pharmacol 55:775\u2013783","journal-title":"Biochem Pharmacol"},{"key":"10_CR38","doi-asserted-by":"publisher","first-page":"15742","DOI":"10.1074\/jbc.273.25.15742","volume":"273","author":"A. Kumar","year":"1998","unstructured":"Kumar A, Middleton A, Chambers TC, Mehta KD (1998b) Differential roles of extracellular signal-regulated kinase-1\/2 and p38(MAPK) in interleukin-1beta-and tumor necrosis factor-alpha-induced low density lipoprotein receptor expression in HepG2 cells. Biol J Chem 273:15742\u201315748","journal-title":"Biol J Chem"},{"key":"10_CR39","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00109-004-0555-y","volume":"82","author":"A. Kumar","year":"2004","unstructured":"Kumar A, Takada Y, Boriek AM, Aggarwal BB (2004) Nuclear factor-kappaB: its role in health and disease. Mol J Med 82:434\u2013448","journal-title":"Mol J Med"},{"key":"10_CR40","first-page":"2866","volume":"45","author":"R. Kurzrock","year":"1985","unstructured":"Kurzrock R, Rosenblum MG, Sherwin SA, Rios A, Talpaz M, Quesada JR, Gutterman JU (1985) Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients. Cancer Res 45:2866\u20132872","journal-title":"Cancer Res"},{"key":"10_CR41","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/372739a0","volume":"372","author":"J.C. Lee","year":"1994","unstructured":"Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, Mc-Nulty D, Blumenthal MJ, Heys JR, Landvatter SW et al (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739\u2013746","journal-title":"Nature"},{"key":"10_CR42","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1002\/art.10583","volume":"46","author":"J.H. Lee","year":"2002","unstructured":"Lee JH, Slifman NR, Gershon SK, Edwards ET, Schwieterman WD, Siegel JN, Wise RP, Brown SL, Udall JN Jr, Braun MM (2002) Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Arthritis Rheum 46:2565\u20132570","journal-title":"Arthritis Rheum"},{"key":"10_CR43","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/00024382-200205000-00010","volume":"17","author":"W. Lukita-Atmadja","year":"2002","unstructured":"Lukita-Atmadja W, Ito Y, Baker GL, McCuskey RS (2002) Effect of curcuminoids as anti-inflammatory agents on the hepatic microvascular response to endotoxin. Shock 17:399\u2013403","journal-title":"Shock"},{"key":"10_CR44","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.4049\/jimmunol.164.11.5815","volume":"164","author":"S.K. Manna","year":"2000","unstructured":"Manna SK, Aggarwal BB (2000) Vesnarinone suppresses TNF-induced activation of NF-kappa B, c-Jun kinase, and apoptosis. Immunol J 164:5815\u20135825","journal-title":"Immunol J"},{"key":"10_CR45","first-page":"3838","volume":"60","author":"S.K. Manna","year":"2000","unstructured":"Manna SK, Sah NK, Newman RA, Cisneros A, Aggarwal BB (2000) Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase. Cancer Res 60:3838\u20133847","journal-title":"Cancer Res"},{"key":"10_CR46","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jbspin.2003.10.008","volume":"71","author":"C. Masson","year":"2004","unstructured":"Masson C, Simon V, Hoppe E, Insalaco P, Cisse I, Audran M (2004) Tumor necrosis factor receptor-associated periodic syndrome (TRAPS): definition, semiology, prognosis, pathogenesis, treatment, and place relative to other periodic joint diseases. Joint Bone Spine 71:284\u2013290","journal-title":"Joint Bone Spine"},{"key":"10_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00403-004-0487-y","volume":"296","author":"D.V. Messadi","year":"2004","unstructured":"Messadi DV, Doung HS, Zhang Q, Kelly AP, Tuan TL, Reichenber E, Le AD (2004) Activation of NFkappaB signal pathways in keloid fibroblasts. Arch Dermatol Res 296:125\u2013133","journal-title":"Arch Dermatol Res"},{"key":"10_CR48","first-page":"1955","volume":"31","author":"N. Mohan","year":"2004","unstructured":"Mohan N, Edwards ET, Cupps TR, Slifman N, Lee JH, Siegel JN, Braun MM (2004) Leukocytoclastic vasculitis associated with tumor necrosis factoralpha blocking agents. Rheumatol J 31:1955\u20131958","journal-title":"Rheumatol J"},{"key":"10_CR49","doi-asserted-by":"publisher","first-page":"31906","DOI":"10.1074\/jbc.M105252200","volume":"276","author":"A. Mukhopadhyay","year":"2001","unstructured":"Mukhopadhyay A, Suttles J, Stout RD, Aggarwal BB (2001) Genetic deletion of the tumor necrosis factor receptor p60 or p80 abrogates ligand-mediated activation of nuclear factor-kappaBand of mitogen-activated protein kinases in macrophages. Biol J Chem 276:31906\u201331912","journal-title":"Biol J Chem"},{"key":"10_CR50","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S0006-2952(03)00419-2","volume":"66","author":"Y. Murakami","year":"2003","unstructured":"Murakami Y, Shoji M, Hanazawa S, Tanaka S, Fujisawa S (2003) Preventive effect of bis-eugenol, a eugenol ortho dimer, on lipopolysaccharide-stimulated nuclear factor kappa B activation and inflammatory cytokine expression in macrophages. Biochem Pharmacol 66:1061\u20131066","journal-title":"Biochem Pharmacol"},{"key":"10_CR51","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1006\/bbrc.1999.1574","volume":"264","author":"K. Murakami-Mori","year":"1999","unstructured":"Murakami-Mori K, Mori S, Nakamura S (1999) p38MAP kinase is a negative regulator for ERK1\/2-mediated growth of AIDS-associated Kaposi\u2019s sarcoma cells. Biochem Biophys Res Commun 264:676\u2013682","journal-title":"Biochem Biophys Res Commun"},{"key":"10_CR52","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1016\/j.bmcl.2004.05.041","volume":"14","author":"T. Murata","year":"2004","unstructured":"Murata T, Shimada M, Sakakibara S, Yoshino T, Masuda T, Shintani T, Sato H, Koriyama Y, Fukushima K, Nunami N, Yamauchi M, Fuchikami K, Komura H, Watanabe A, Ziegelbauer KB, Bacon KB, Lowinger TB (2004) Synthesis and structure-activity relationships of novel IKK-beta inhibitors. Part 3: orally active anti-inflammatory agents. Bioorg Med ChemLett 14:4019\u20134022","journal-title":"Bioorg Med ChemLett"},{"key":"10_CR53","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1126\/science.7533326","volume":"267","author":"S. Nagata","year":"1995","unstructured":"Nagata S, Golstein P (1995) The Fas death factor. Science 267:1449\u20131456","journal-title":"Science"},{"key":"10_CR54","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/43466","volume":"401","author":"O.N. Ozes","year":"1999","unstructured":"Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB (1999) NF-kappaB activation by tumour necrosis factor requires the Akt serinethreonine kinase. Nature 401:82\u201385","journal-title":"Nature"},{"key":"10_CR55","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1016\/j.bmcl.2003.08.047","volume":"13","author":"M.S. Palanki","year":"2003","unstructured":"Palanki MS, Erdman PE, Ren M, Suto M, Bennett BL, Manning A, Ransone L, Spooner C, Desai S, Ow A, Totsuka R, Tsao P, Toriumi W (2003) The design and synthesis of novel orally active inhibitors of AP-1 and NFkappaB mediated transcriptional activation. SAR of in vitro and in vivo studies. Bioorg Med Chem Lett 13:4077\u20134080","journal-title":"Bioorg Med Chem Lett"},{"key":"10_CR56","doi-asserted-by":"publisher","first-page":"19411","DOI":"10.1074\/jbc.274.27.19411","volume":"274","author":"J.G. Pastorino","year":"1999","unstructured":"Pastorino JG, Tafani M, Farber JL (1999) Tumor necrosis factor induces phosphorylation and translocation of BAD through a phosphatidylinositide-3-OH kinase-dependent pathway. Biol J Chem 274:19411\u201319416","journal-title":"Biol J Chem"},{"key":"10_CR57","doi-asserted-by":"publisher","first-page":"55161","DOI":"10.1074\/jbc.M411049200","volume":"279","author":"W. Reiley","year":"2004","unstructured":"Reiley W, Zhang M, Sun SC (2004) Negative regulation of JNK signaling pathway by the tumor suppressor CYLD. Biol J Chem 279:55161\u201355167","journal-title":"Biol J Chem"},{"key":"10_CR58","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1111\/j.1572-0241.2004.40462.x","volume":"99","author":"W.J. Sandborn","year":"2004","unstructured":"Sandborn WJ, Hanauer S, Loftus EV Jr, Tremaine WJ, Kane S, Cohen R, Hanson K, Johnson T, Schmitt D, Jeche R (2004) An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn\u2019s disease. Am Gastroente Jrol 99:1984\u20131989","journal-title":"Am Gastroente Jrol"},{"key":"10_CR59","first-page":"4375","volume":"63","author":"S. Shishodia","year":"2003","unstructured":"Shishodia S, Majumdar S, Banerjee S, Aggarwal BB (2003) Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res 63:4375\u20134383","journal-title":"Cancer Res"},{"key":"10_CR60","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/art.10758","volume":"48","author":"N.R. Slifman","year":"2003","unstructured":"Slifman NR, Gershon SK, Lee JH, Edwards ET, Braun MM (2003) Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Arthritis Rheum 48:319\u2013324","journal-title":"Arthritis Rheum"},{"key":"10_CR61","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.1021\/jm049194+","volume":"47","author":"R.J. Steffan","year":"2004","unstructured":"Steffan RJ, Matelan E, Ashwell MA, Moore WJ, Solvibile WR, Trybulski E, Chadwick CC, Chippari S, Kenney T, Eckert A, Borges-Marcucci L, Keith JC, Xu Z, Mosyak L, Harnish DC (2004) Synthesis and activity of substituted 4-(indazol-3-yl)phenols as pathway-selective estrogen receptor ligands useful in the treatment of rheumatoid arthritis. J Med Chem 47:6435\u20136438","journal-title":"J Med Chem"},{"key":"10_CR62","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1126\/science.3933111","volume":"230","author":"B.J. Sugarman","year":"1985","unstructured":"Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA Jr, Shepard HM (1985) Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 230:943\u2013945","journal-title":"Science"},{"key":"10_CR63","first-page":"780","volume":"47","author":"B.J. Sugarman","year":"1987","unstructured":"Sugarman BJ, Lewis GD, Eessalu TE, Aggarwal BB, Shepard HM (1987) Effects of growth factors on the antiproliferative activity of tumor necrosis factors. Cancer Res 47:780\u2013786","journal-title":"Cancer Res"},{"key":"10_CR64","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.4049\/jimmunol.171.6.3278","volume":"171","author":"Y. Takada","year":"2003","unstructured":"Takada Y, Aggarwal BB (2003a) Betulinic acid suppresses carcinogen-induced NF-kappa B activation through inhibition of I kappa B alpha kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9. Immunol J 171:3278\u20133286","journal-title":"Immunol J"},{"key":"10_CR65","doi-asserted-by":"publisher","first-page":"23390","DOI":"10.1074\/jbc.M213237200","volume":"278","author":"Y. Takada","year":"2003","unstructured":"Takada Y, Aggarwal BB (2003b) Genetic deletion of the tumor necrosis factor receptor p60 or p80 sensitizes macrophages to lipopolysaccharide-induced nuclear factor-kappa B, mitogen-activated protein kinases, and apoptosis. Biol J Chem 278:23390\u201323397","journal-title":"Biol J Chem"},{"key":"10_CR66","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1182\/blood-2004-04-1607","volume":"104","author":"Y. Takada","year":"2004","unstructured":"Takada Y, Aggarwal BB (2004) Evidence that genetic deletion of the TNF receptor p60 or p80 in macrophages modulates RANKL-induced signaling. Blood 104:4113\u20134121","journal-title":"Blood"},{"key":"10_CR67","doi-asserted-by":"crossref","first-page":"18542","DOI":"10.1016\/S0021-9258(17)46661-0","volume":"268","author":"L.A. Tartaglia","year":"1993","unstructured":"Tartaglia LA, Pennica D, Goeddel DV (1993) Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruitsTNFfor signaling by the 55-kDaTNF receptor. Biol J Chem 268:18542\u201318548","journal-title":"Biol J Chem"},{"key":"10_CR68","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ejphar.2004.06.056","volume":"497","author":"A. Torii","year":"2004","unstructured":"Torii A, Miyake M, Morishita M, Ito K, Torii S, Sakamoto T (2004)Vitamin A reduces lung granulomatous inflammation with eosinophilic and neutrophilic infiltration in Sephadex-treated rats. Eur Pharmacol J 497:335\u2013342","journal-title":"Eur Pharmacol J"},{"key":"10_CR69","doi-asserted-by":"publisher","first-page":"16484","DOI":"10.1074\/jbc.M010384200","volume":"276","author":"S.E. Tran","year":"2001","unstructured":"Tran SE, Holmstrom TH, Ahonen M, Kahari VM, Eriksson JE (2001) MAPK\/ERK overrides the apoptotic signaling from Fas, TNF, TRAIL receptors. Biol J Chem 276:16484\u201316490","journal-title":"Biol J Chem"},{"key":"10_CR70","doi-asserted-by":"publisher","first-page":"12940","DOI":"10.1073\/pnas.0400949101","volume":"101","author":"S.J. Tucker","year":"2004","unstructured":"Tucker SJ, Rae C, Littlejohn AF, Paul A, MacEwan DJ (2004) Switching leukemia cell phenotype between life and death. Proc Natl Acad Sci U S A 101:12940\u201312945","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10_CR71","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1074\/jbc.273.6.3285","volume":"273","author":"W. Vanden Berghe","year":"1998","unstructured":"Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W, Haegeman G (1998) p38 and extracellular signal-regulated kinase mitogen-activated protein kinasepathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. Biol J Chem 273:3285\u20133290","journal-title":"Biol J Chem"},{"key":"10_CR72","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1086\/346053","volume":"187","author":"R.S. Wallis","year":"2003","unstructured":"Wallis RS, Vinhas SA, Johnson JL, Ribeiro FC, Palaci M, Peres RL, Sa RT, Dietze R, Chiunda A, Eisenach K, Ellner JJ (2003) Whole blood bactericidal activity during treatment of pulmonary tuberculosis. Infect J Dis 187:270\u2013278","journal-title":"Infect J Dis"},{"key":"10_CR73","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/art.20311","volume":"50","author":"F. Wolfe","year":"2004","unstructured":"Wolfe F, Michaud K (2004) Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 50:1740\u20131751","journal-title":"Arthritis Rheum"},{"key":"10_CR74","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1158\/0008-5472.CAN-04-0343","volume":"64","author":"L. Yang","year":"2004","unstructured":"Yang L, Dan HC, Sun M, Liu Q, Sun XM, Feldman RI, Hamilton AD, Polokoff M, Nicosia SV, Herlyn M, Sebti SM, Cheng JQ (2004) Akt\/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res 64:4394\u20134399","journal-title":"Cancer Res"}],"container-title":["Ernst Schering Research Foundation Workshop","Cytokines as Potential Therapeutic Targets for Inflammatory Skin Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/3-540-37673-9_10.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T15:22:10Z","timestamp":1683645730000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/3-540-37673-9_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["9783540254270"],"references-count":74,"URL":"https:\/\/doi.org\/10.1007\/3-540-37673-9_10","relation":{},"subject":[]}}